paclitaxel has been researched along with Leukemia, Pre-B-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cunningham, T; Müller, F; Pastan, I; Stookey, S | 1 |
| Bhalla, K; Bullock, G; Huang, Y; Mahoney, ME; Miyashita, T; Ponnathpur, V; Ray, S; Reed, JC; Tang, C; Willingham, MC | 1 |
2 other study(ies) available for paclitaxel and Leukemia, Pre-B-Cell
| Article | Year |
|---|---|
Paclitaxel synergizes with exposure time adjusted CD22-targeting immunotoxins against B-cell malignancies.
Topics: Animals; Antineoplastic Agents; Bacterial Toxins; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Exotoxins; Humans; Immunotoxins; Mice; Paclitaxel; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Sialic Acid Binding Ig-like Lectin 2; Treatment Outcome; Xenograft Model Antitumor Assays | 2017 |
High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; DNA Damage; DNA, Neoplasm; In Vitro Techniques; Microtubules; Paclitaxel; Phosphoproteins; Phosphotyrosine; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tubulin; Tumor Cells, Cultured; Tyrosine | 1994 |